tafoxiparin
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2007 (NCT00710242)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Heparan sulfateSupplementation
Heparan sulfate supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tafoxiparin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04000438 | Phase 2 | Jun 21, 2019 | Dilafor AB, Union Therapeutics |
| NCT03001193 | Phase 2 | Dec 1, 2016 | Dilafor AB |
| NCT00710242 | Phase 2 | Apr 1, 2007 | Dilafor AB, Kvinnokliniken Sodra Alvsborgs sjukhus Boras |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dilafor AB | For profit | 3 | 3 | 1 | 2007 |
| Kvinnokliniken Sodra Alvsborgs sjukhus Boras | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Union Therapeutics | For profit | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1